Literature DB >> 33707856

Primary Mediastinal B Cell Lymphoma: A Limited Institutional Experience with Uniform DAEPOCH-R Protocol.

Ajay Gogia1, Sudhir Kumar1, Santosh Kumar Chellapurum1, Ahitagni Biswas2, Soumya Mallick3.   

Abstract

Entities:  

Year:  2020        PMID： 33707856      PMCID： PMC7900323          DOI： 10.1007/s12288-020-01301-z

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  9 in total

1.  Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.

Authors:  Lisa Giulino-Roth; Tara O'Donohue; Zhengming Chen; Nancy L Bartlett; Ann LaCasce; William Martin-Doyle; Matthew J Barth; Kimberly Davies; Kristie A Blum; Beth Christian; Carla Casulo; Sonali M Smith; James Godfrey; Amanda Termuhlen; Matthew J Oberley; Sarah Alexander; Sheila Weitzman; Burton Appel; Benjamin Mizukawa; Jakub Svoboda; Zeinab Afify; Melinda Pauly; Hema Dave; Rebecca Gardner; Deborah M Stephens; William A Zeitler; Christopher Forlenza; Jennifer Levine; Michael E Williams; Jody L Sima; Catherine M Bollard; John P Leonard
Journal:  Br J Haematol       Date:  2017-10-29       Impact factor: 6.998

2.  The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients.

Authors:  Pier Luigi Zinzani; Alessandro Broccoli; Beatrice Casadei; Vittorio Stefoni; Cinzia Pellegrini; Letizia Gandolfi; Roberto Maglie; Lisa Argnani; Stefano Pileri; Stefano Fanti
Journal:  Hematol Oncol       Date:  2014-09-25       Impact factor: 5.271

3.  Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial.

Authors:  Mary Gleeson; Eliza A Hawkes; David Cunningham; Nick Chadwick; Nicholas Counsell; Anthony Lawrie; Andrew Jack; Paul Smith; Paul Mouncey; Christopher Pocock; Kirit M Ardeshna; John Radford; Andrew McMillan; John Davies; Deborah Turner; Anton Kruger; Peter W M Johnson; Joanna Gambell; David Linch
Journal:  Br J Haematol       Date:  2016-08-01       Impact factor: 6.998

4.  P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines.

Authors:  G M Lai; Y N Chen; L A Mickley; A T Fojo; S E Bates
Journal:  Int J Cancer       Date:  1991-11-11       Impact factor: 7.396

5.  Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.

Authors:  Bruce D Cheson; Richard I Fisher; Sally F Barrington; Franco Cavalli; Lawrence H Schwartz; Emanuele Zucca; T Andrew Lister
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

Review 6.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

Review 7.  How I treat primary mediastinal B-cell lymphoma.

Authors:  Lisa Giulino-Roth
Journal:  Blood       Date:  2018-07-05       Impact factor: 22.113

8.  DA-EPOCH-R in Aggressive CD 20 Positive B Cell Lymphomas: Real-World Experience.

Authors:  Prasanth Ganesan; Trivadi S Ganesan; Harshvardhan Atreya; Krishnarathinam Kannan; Venkatraman Radhakrishnan; Manikandan Dhanushkodi; Thanda Lucy Ann Joshua; Shirley Sundersingh; Tenali Gnana Sagar
Journal:  Indian J Hematol Blood Transfus       Date:  2017-11-04       Impact factor: 0.900

9.  Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.

Authors:  Kieron Dunleavy; Stefania Pittaluga; Lauren S Maeda; Ranjana Advani; Clara C Chen; Julie Hessler; Seth M Steinberg; Cliona Grant; George Wright; Gaurav Varma; Louis M Staudt; Elaine S Jaffe; Wyndham H Wilson
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245
  9 in total
  2 in total

1.  Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience.

Authors:  Hasmukh Jain; Akhil Kapoor; Manju Sengar; Raajit Chanana; Hari Menon; Epari Sridhar; Siddhartha Laskar; Archi Agarwal; Jayant Shastri; Nehal Khanna; Venkatesh Rangarajan; Bhausaheb Bagal; Jayashree Thorat; Tanuja Shet; Sumeet Gujral
Journal:  Indian J Hematol Blood Transfus       Date:  2021-03-01       Impact factor: 0.915

Review 2.  Pediatric mediastinal lymphoma.

Authors:  Saumyaranjan Mallick; Surabhi Jain; Prashant Ramteke
Journal:  Mediastinum       Date:  2020-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.